Boothbay Fund Management, LLC Cassava Sciences Inc Call Options Transaction History

Boothbay Fund Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $1.73 Million - $5.59 Million	-41,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $1.33 Million - $3.71 Million	41,300 New	41,300 $3.53 Million

184

13.3M

1.38M

2.04M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.22B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.